|4Feb 25, 4:33 PM ET

Bonaccorso Joe 4

4 · Verrica Pharmaceuticals Inc. · Filed Feb 25, 2022

Insider Transaction Report

Form 4
Period: 2022-02-24
Bonaccorso Joe
CHIEF COMMERCIAL OFFICER
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-02-24+75,00075,000 total
    Exercise: $8.00Exp: 2032-02-23Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]25% of the total shares subject to the option shall vest on February 24, 2023 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION